May 05, 2019 - Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Q1 2019 Earnings Conference Call May 02, 2019, 08:30 ET Company Participants Patricia Eisenhaur - VP, IR & Communications Craig Wheeler - President, CEO
May 02, 2019 - MNTA earnings call for the period ending March 31, 2019.
Apr 25, 2019 - Momenta (MNTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mar 27, 2019 - Novartis (NVS) obtains FDA approval for Mayzent for the treatment of relapsing forms of MS.
Feb 25, 2019 - Momenta (MNTA) reported a narrower loss in Q4, while sales came ahead of expectations.
Feb 22, 2019 - MNTA earnings call for the period ending December 31, 2018.
Feb 22, 2019 - Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Q4 2018 Earnings Conference Call February 22, 2019, 08:30 ET Company Participants Patty Eisenhaur - VP, Investor Relations and Corporate Communications Crai
Feb 22, 2019 - Momenta (MNTA) delivered earnings and revenue surprises of 84.78% and 102.47%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Feb 15, 2019 - Momenta (MNTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dec 11, 2018 - Volatility strikes the biotech.